R Kancherla

492 total citations
14 papers, 380 citations indexed

About

R Kancherla is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, R Kancherla has authored 14 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in R Kancherla's work include Lymphoma Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (2 papers) and Acute Myeloid Leukemia Research (2 papers). R Kancherla is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (2 papers) and Acute Myeloid Leukemia Research (2 papers). R Kancherla collaborates with scholars based in United States. R Kancherla's co-authors include Tauseef Ahmed, Jen Wei Chiao, Abraham Mittelman, C. Clifford Conaway, Fung‐Lung Chung, Yuling Yang, Jinshyun R. Wu‐Wong, B S Moonga, Karen Seiter and T C Hsieh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

R Kancherla

14 papers receiving 370 citations

Peers

R Kancherla
Sathyen A. Prabhu United States
Guiqin Hou China
Ranadip Mandal Germany
Shingo Nakashima Japan
Rong H. Zhang United States
Fabiola Sesti Italy
Yichao Gan China
Yoshihiko Shibayama Japan
Sung Lyea Park South Korea
Liz J. Hernández Borrero United States
Sathyen A. Prabhu United States
R Kancherla
Citations per year, relative to R Kancherla R Kancherla (= 1×) peers Sathyen A. Prabhu

Countries citing papers authored by R Kancherla

Since Specialization
Citations

This map shows the geographic impact of R Kancherla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Kancherla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Kancherla more than expected).

Fields of papers citing papers by R Kancherla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Kancherla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Kancherla. The network helps show where R Kancherla may publish in the future.

Co-authorship network of co-authors of R Kancherla

This figure shows the co-authorship network connecting the top 25 collaborators of R Kancherla. A scholar is included among the top collaborators of R Kancherla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Kancherla. R Kancherla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kancherla, R, Zeeshan Qureshi, Albert Hoang, et al.. (2005). High-dose therapy with autologous stem cell rescue in patients with breast cancer at high risk for relapse. Journal of Clinical Oncology. 23(16_suppl). 824–824. 1 indexed citations
2.
Ahmed, Tauseef, R Kancherla, Zeeshan Qureshi, et al.. (2004). Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant. Leukemia & lymphoma. 46(3). 405–414. 9 indexed citations
3.
Kancherla, R, et al.. (2004). Progressively Intensified Chemotherapy: A Phase II Trial in Patients with Multiple Myeloma.. Blood. 104(11). 4951–4951. 1 indexed citations
4.
5.
Chiao, Jen Wei, Fung‐Lung Chung, R Kancherla, et al.. (2002). Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. International Journal of Oncology. 20(3). 631–6. 170 indexed citations
6.
7.
Chiao, Jen Wei, B S Moonga, Yuling Yang, et al.. (2000). Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption. British Journal of Cancer. 83(3). 360–365. 87 indexed citations
8.
Ahmed, Tauseef, R Kancherla, Zeeshan Qureshi, et al.. (2000). High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome. Bone Marrow Transplantation. 25(10). 1041–1045. 5 indexed citations
9.
Nair, Jayasree S., R Kancherla, Karen Seiter, Frank Traganos, & Yuk‐Ching Tse‐Dinh. (2000). Action of Topoisomerase Targeting Drugs on Non‐Hodgkin's Lymphoma and Leukemia: Correlation of Clinical and Cell Culture Studies. Annals of the New York Academy of Sciences. 922(1). 326–329. 4 indexed citations
10.
11.
Ikehara, Susumu, Yasushi Adachi, Shuo Quan, et al.. (1999). Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer.. International Journal of Oncology. 14(6). 1143–51. 9 indexed citations
12.
Chiao, Jen Wei, Wei Xu, Yuling Yang, et al.. (1999). Regulation of growth and apoptosis of breast cancer cells by a 54 kDa lymphokine.. International Journal of Oncology. 15(4). 835–8. 1 indexed citations
13.
Chiao, Jen Wei, et al.. (1999). Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1.. International Journal of Oncology. 15(5). 1033–7. 31 indexed citations
14.
Ahmed, Tauseef, M. Beer, Karen Seiter, et al.. (1997). Single and double autotransplants for relapsing/refractory Hodgkin’s disease: results of two consecutive trials. Bone Marrow Transplantation. 19(5). 449–454. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sathyen A. Prabhu Breakdown of academic impact, for papers by Guiqin Hou Breakdown of academic impact, for papers by Ranadip Mandal Breakdown of academic impact, for papers by Shingo Nakashima Breakdown of academic impact, for papers by Rong H. Zhang Breakdown of academic impact, for papers by Fabiola Sesti Breakdown of academic impact, for papers by Yichao Gan Breakdown of academic impact, for papers by Yoshihiko Shibayama Breakdown of academic impact, for papers by Sung Lyea Park Breakdown of academic impact, for papers by Liz J. Hernández Borrero
Rankless by CCL
2026